Gut Microbiota and Endometriosis: Exploring the Relationship and Therapeutic Implications
Pharmaceuticals · 07.12.2023 · 16 (12) · 1696
DOI: 10.3390/ph16121696 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 07.12.2023. Verfasst von Anjeza Xholli und 4 weiteren Autor:innen. Beteiligte Einrichtung: Academic Unit of Obstetrics and Gynecology, IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Endometriosis is a common inflammatory disease affecting women of reproductive age, characterized by the growth of endometrial tissue beyond the uterus. In addition to gynecological manifestations, many endometriosis patients experience gastrointestinal symptoms, indicating a potential association between gut health and the disease. Recent studies have revealed alterations in the gut microbiota of individuals with endometriosis, including reduced diversity, microbial composition imbalances, and pathogenic bacteria. These changes can disrupt immune function, increase inflammation, and contribute to the chronic inflammatory state observed in endometriosis. Moreover, dysregulation of intestinal permeability may further exacerbate gastrointestinal symptoms in affected individuals. Understanding the role of the gut microbiota and intestinal permeability in endometriosis can provide valuable insights into disease pathogenesis, aid in non-invasive diagnostic approaches, and open new avenues for therapeutic interventions. Probiotics, in particular, have shown promise in improving endometriosis-associated pain symptoms and reducing endometriotic lesions in animal models. This review suggests that additional research and well-designed clinical trials are necessary to validate the potential diagnostic and therapeutic benefits of manipulating the gut microbiota in managing endometriosis and its gastrointestinal symptoms, thereby improving the quality of life for those affected.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Academic Unit of Obstetrics and Gynecology, IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.
- Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Infant Health, University of Genoa, 16132 Genova, Italy.
- Obstetrics and Gynecology Unit, IRCCS Istituto Giannina Gaslini, 16147 Genova, Italy.
ORCID-Profile: Anjeza Xholli, Francesca Cremonini, Ambrogio Pietro Londero, Angelo Cagnacci
Zitieren
APA
Xholli, A., Cremonini, F., Perugi, I., Londero, A. P., & Cagnacci, A. (2023). Gut Microbiota and Endometriosis: Exploring the Relationship and Therapeutic Implications. Pharmaceuticals, 16(12), 1696. https://doi.org/10.3390/ph16121696
Vancouver
Xholli A, Cremonini F, Perugi I, Londero AP, Cagnacci A. Gut Microbiota and Endometriosis: Exploring the Relationship and Therapeutic Implications. Pharmaceuticals. 2023;16(12):1696. doi:10.3390/ph16121696
BibTeX
@article{Xholli2023,
author = {Xholli, Anjeza and Cremonini, Francesca and Perugi, Isabella and Londero, Ambrogio Pietro and Cagnacci, Angelo},
title = {Gut Microbiota and Endometriosis: Exploring the Relationship and Therapeutic Implications},
journal = {Pharmaceuticals},
year = {2023},
volume = {16},
number = {12},
pages = {1696},
doi = {10.3390/ph16121696}
}
EUVIMED